Your body relies on the INS gene to make insulin, the hormone that helps move sugar from the blood into cells for energy. If this gene does not work as it should, blood sugar can become too high and some people develop diabetes, sometimes starting in the first months of life. Certain variants in the INS gene can also change how insulin is folded and released by the pancreas.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. If you want to look into this topic more deeply, you can find more in the LearnHub.
Overview
INSGene function
What if the gene works
The INS gene provides instructions for making insulin, a hormone made in the pancreas. Insulin helps move sugar from the blood into cells and helps keep blood sugar in a healthy range.
Risk
What if the gene does not work
Variants in the INS gene can disrupt insulin production or folding. Milder changes may contribute to diabetes, while more severe variants can cause diabetes in infancy; some variants instead raise insulin release and lead to low blood sugar.
Treatment
What does that mean for your treatment
Pathogenic variants in the INS gene usually mean diabetes is treated with insulin replacement, often from diagnosis. Unlike diabetes caused by the KCNJ11 gene or the ABCC8 gene, diabetes due to INS variants does not usually switch to sulfonylurea medicines, so treatment choices generally remain centered on insulin and standard diabetes care.
Conditions associated with INS
Gene function
What if the gene works
After you eat, your body needs a clear signal to move sugar from the blood into tissues that can use it. The INS gene provides that signal by making insulin in special cells of the pancreas. This is a simple way to understand how the INS gene controls blood sugar and helps your body handle energy from one meal to the next.
The INS gene gives special pancreas cells the instructions to make insulin. Those cells first build a longer starter protein, then trim it into the insulin used for everyday signaling.
After a meal, insulin acts like a message that tells muscle, fat, and other tissues that fuel is available. This helps glucose move out of the bloodstream and into cells that can use it or save it for later.
Insulin tells the liver and muscles to store extra glucose for later use. It also signals the liver to slow its own glucose release, which supports a steadier blood sugar level between meals.
Insulin helps the body shift from breaking down fuel to storing and using nutrients in a controlled way. It supports making glycogen (stored sugar), fat, and protein when food is available.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. They are common and help explain normal variation between people, including differences in appearance, metabolism, and the way the body reacts to environmental factors. Many do not cause any noticeable effects and are part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the INS gene can change how insulin is made inside pancreatic beta cells. Many variants alter the insulin building block so it folds incorrectly, gets trapped inside the cell, and causes cell stress. Others reduce how much usable insulin is produced. In practical terms, how INS gene variants affect insulin production ranges from milder changes with partial activity to more disruptive variants with little or no usable insulin, often linking to earlier diabetes onset.
How variants are linked to conditions
Pathogenic variants in the INS gene can cause permanent neonatal diabetes, often recognized in the first 6 months of life, and some can lead to a later onset inherited form of diabetes called MODY. A smaller group of INS gene variants is linked to low blood sugar caused by too much insulin. Common INS gene changes have also been associated with type 1 diabetes risk, but these risk markers do not mean a person will definitely develop diabetes.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology. Most do not directly affect health and simply reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For disease-causing changes in the INS gene, the main risk comes from the gene change itself, not from lifestyle. A family history of an INS-related condition can raise the chance of carrying the same change. If someone has an INS-related condition, regular follow-up can help spot blood sugar problems early and prevent complications.
Inheritance of INS variants
Variants in the INS gene can be inherited in different ways, depending on the specific condition they cause. In families asking how INS gene variants are inherited, the best known pattern is autosomal dominant, which means a parent with the variant can pass it to each child with a 50% chance, and some cases happen as a new de novo variant. Other INS-related conditions follow an autosomal recessive pattern, which means a child inherits one changed copy from each parent. Because of this, inheritance in the INS gene is not described by one single pattern for every situation.
What does my INS result mean for my family?
For INS, what it means for family members depends on the exact condition linked to the result. Some INS changes are passed down in families in a dominant way, so close relatives may also carry the same change and may want to discuss testing; other INS changes are recessive, which means relatives may be healthy carriers. In some families, an INS change can be new in one person rather than inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
A blood or saliva sample can be used for INS gene testing for neonatal diabetes and some inherited forms of early-onset diabetes. The lab reads the DNA code of the INS gene to look for variants. Results can confirm a genetic cause in some people, while a normal result may point doctors to other diabetes genes.
When should I consider getting a genetic test?
Testing for changes in the INS gene may be considered if diabetes starts very early in life, especially in the first 6 months, or if several relatives developed diabetes at a young age without the usual signs of type 1 diabetes. It can also help explain ongoing high blood sugar in a baby or child when the cause is unclear.
A genetic result is only one part of your health story
Genetic test results can be very informative, but what they tell you varies based on the condition and the kind of variant involved. Over time, the way the body works is also shaped by lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or reacts to a drug, so the same treatment may work better for one person than another. This is common and can influence how much benefit someone gets or how likely they are to have side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medication. It looks at connections between genes and drugs to help explain why the same treatment works differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can help guide treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the INS gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about symptoms, diabetes care, or side effects from any treatment are best discussed with your doctor.
History
The history of the INS gene is closely tied to one of medicine’s most important breakthroughs. In 1921, the discovery of insulin transformed type 1 diabetes from a usually fatal illness into a treatable condition. Scientists later worked out that this hormone was made from instructions carried in the INS gene, and this helped connect clinical care with modern genetics. In recent decades, knowledge has built on a long tradition of observing inherited traits. A major milestone came in the late 1970s and early 1980s, when the INS gene was cloned and used to make recombinant human insulin. That step changed treatment worldwide and marked an early success for gene based biotechnology.